Wells Fargo & Company Aura Biosciences, Inc. Transaction History
Wells Fargo & Company
- $433 Billion
- Q4 2024
A detailed history of Wells Fargo & Company transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 27,623 shares of AURA stock, worth $204,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,623
Previous 21,693
27.34%
Holding current value
$204,410
Previous $193,000
17.62%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AURA
# of Institutions
95Shares Held
39.9MCall Options Held
1.9KPut Options Held
31K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$51.2 Million2.75% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$36.1 Million0.07% of portfolio
-
Eventide Asset Management, LLC Boston, MA4.08MShares$30.2 Million0.64% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$22.5 Million5.49% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$22.2 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $217M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...